硕世生物,688399,收入构成,报告日期,2019-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
体外诊断行业,28285,4854,23431,82.84%,99.24%
其他（补充）,595,415,180,30.24%,0.76%


